Web-based training and certification of clinical staff during the randomised clinical trial SafeBoosC-III

Marie Isabel Skov Rasmussen,Mathias Lühr Hansen,Colin Peters,Gorm Greisen,SafeBoosC-III Trial Group,Adelina Pellicer,Afif El-Kuffash,Agata Bargiel,Ana Alarcon,Andrew Hopper,Anita Truttmann,Anja Hergenhan,Anja Klamer,Anna Curley,Anne Marie Heuchan,Anne Smits,Asli Cinar Memisoglu,Barbara Krolak-Olejnik,Beata Rzepecka,Begona Loureiro Gonzales,Beril Yasa,Berndt Urlesberger,Catalina Morales-Betancourt,Chantal Lecart,Christian Gluud,Claudia Knöepfli,Cornelia Hagmann,David Healy,Ebru Ergenekon,Eleftheria Hatzidaki,Elena Bergon-Sendin,Eleni Skylogianni,Elzbieta Rafinska-Wazny,Emmanuele Mastretta,Eugene Dempsey,Eva Valverde,Evangelina Papathoma,Fabio Mosca,Gabriel Dimitriou,Gerhard Pichler,Giovanni Vento,Gitte Holst Hahn,Gunnar Naulaers,Guoqiang Cheng,Hans Fuchs,Hilal Ozkan,Isabel De Las Cuevas,Itziar Serrano-Vinuales,Iwona Sadowska-Krawczenko,Jachym Kucera,Jakub Tkaczyk,Jan Miletin,Jan Sirc,Janus Christian Jakobsen,Jana Baumgartner,Jonathan Mintzer,Julie De Buyst,Karen McCall,Konstantina Tsoni,Kosmas Sarafidis,Lars Bender,Laura Serrano Lopez,Le Wang,Liesbeth Thewissen,Lin Huijia,Lina Chalak,Ling Yang,Luc Cornette,Luis Arruza,Maria Wilinska,Mariana Baserga,Marta Mencia Ybarra,Marta Teresa Palacio,Martin Stocker,Massimo Agosti,Merih Cetinkaya,Miguel Alsina,Monica Fumagalli,Munaf M. Kadri,Mustafa Senol Akin,Münevver Baş,Nilgun Koksal,Olalla Otero Vaccarello,Olivier Baud,Pamela Zafra,Peter Agergaard,Peter Korcek,Pierre Maton,Rebeca Sanchez-Salmador,Ruth del Rio Florentino,Ryszard Lauterbach,Salvador Piris Borregas,Saudamini Nesargi,Serife Suna,Shashidhar Appaji Rao,Shujuan Zeng,Silvia Pisoni,Simon Hyttel-Sørensen,Sinem Gulcan Kersin,Siv Fredly,Suna Oguz,Sylwia Marciniak,Tanja Karen,Tomasz Szczapa,Tone Nordvik,Veronika Karadyova,Xiaoyan Gao,Xin Xu,Zachary Vesoulis,Zhang Peng,Zhaoqing Yin
DOI: https://doi.org/10.1186/s13063-024-08530-x
IF: 2.728
2024-10-26
Trials
Abstract:SafeBoosC-III is a pragmatic, multinational clinical trial evaluating cerebral oximetry-guided treatment for extremely preterm infants. In total, 1601 infants were randomised across 70 sites in Asia, Europe, and USA. To enhance data quality and patient care, a web-based training program was implemented for staff. We now report on the processes.
medicine, research & experimental
What problem does this paper attempt to address?